Neogen Chemicals Share Price
Sector: Chemical Manufacturing
1573.55 +38.40 (2.50%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1521.00
Today’s High
1573.55
52 Week Low
1390.50
52 Week High
2414.90
1566.40 +32.70 (2.13%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1520.10
Today’s High
1572.00
52 Week Low
1378.05
52 Week High
2420.00
Key Metrics
- Market Cap (In Cr) 4152.64
- Beta 0.78
- Div. Yield (%) 0.07
- P/B 5.13
- TTM P/E 116.83
- Peg Ratio -12.04
- Sector P/E 17.01
- D/E 0.01
- Open Price 1535.15
- Prev Close 1535.15
Neogen Chemicals Analysis
Price Analysis
-
1 Week-0.6%
-
3 Months-11.75%
-
6 Month-20.53%
-
YTD-31.26%
-
1 Year5.17%
Risk Meter
- 57% Low risk
- 57% Moderate risk
- 57% Balanced Risk
- 57% High risk
- 57% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 5
- 5
- 5
- 5
- Buy
- 2
- 3
- 3
- 3
- Hold
- 1
- 1
- 1
- 1
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 8
- 9
- 9
- 9
Neogen Chemicals News
Stocks to Watch post Budget 2025: Jewellery, FMCG stocks, GR Infra, and more
2 min read . 03 Feb 2025Stocks to buy: Two stock recommendations from MarketSmith India for 10 January
2 min read . 10 Jan 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 20 Sep 2024Neogen Chemicals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 777.56
- Selling/ General/ Admin Expenses Total
- 64.84
- Depreciation/ Amortization
- 27.79
- Other Operating Expenses Total
- 153.34
- Total Operating Expense
- 683.11
- Operating Income
- 94.45
- Net Income Before Taxes
- 50.16
- Net Income
- 34.83
- Diluted Normalized EPS
- 16.91
- Period
- 2025
- Total Assets
- 1747.31
- Total Liabilities
- 957.92
- Total Equity
- 789.39
- Tangible Book Valueper Share Common Eq
- 298.86
- Period
- 2025
- Cashfrom Operating Activities
- 195.96
- Cashfrom Investing Activities
- -316.59
- Cashfrom Financing Activities
- 113.07
- Net Changein Cash
- -7.56
- Period
- 2024
- Total Revenue
- 690.67
- Selling/ General/ Admin Expenses Total
- 120.91
- Depreciation/ Amortization
- 22.87
- Other Operating Expenses Total
- 4.54
- Total Operating Expense
- 603.49
- Operating Income
- 87.18
- Net Income Before Taxes
- 52.77
- Net Income
- 35.65
- Diluted Normalized EPS
- 13.96
- Period
- 2024
- Total Assets
- 1461.4
- Total Liabilities
- 701.11
- Total Equity
- 760.29
- Tangible Book Valueper Share Common Eq
- 287.75
- Period
- 2024
- Cashfrom Operating Activities
- -29.15
- Cashfrom Investing Activities
- -215.58
- Cashfrom Financing Activities
- 236.53
- Net Changein Cash
- -8.2
- Period
- 2023
- Total Revenue
- 686.18
- Selling/ General/ Admin Expenses Total
- 82.15
- Depreciation/ Amortization
- 16.2
- Other Operating Expenses Total
- 0.07
- Total Operating Expense
- 590.76
- Operating Income
- 95.42
- Net Income Before Taxes
- 71.03
- Net Income
- 49.97
- Diluted Normalized EPS
- 20.04
- Period
- 2023
- Total Assets
- 1053.8
- Total Liabilities
- 571.28
- Total Equity
- 482.52
- Tangible Book Valueper Share Common Eq
- 192.91
- Period
- 2023
- Cashfrom Operating Activities
- -30.35
- Cashfrom Investing Activities
- -94.46
- Cashfrom Financing Activities
- 100.29
- Net Changein Cash
- -24.52
- Period
- 2022
- Total Revenue
- 487.25
- Selling/ General/ Admin Expenses Total
- 53.01
- Depreciation/ Amortization
- 11.69
- Other Operating Expenses Total
- 0.17
- Total Operating Expense
- 412.35
- Operating Income
- 74.9
- Net Income Before Taxes
- 57.07
- Net Income
- 44.63
- Diluted Normalized EPS
- 17.9
- Period
- 2022
- Total Assets
- 799.26
- Total Liabilities
- 360.02
- Total Equity
- 439.24
- Tangible Book Valueper Share Common Eq
- 176.06
- Period
- 2022
- Cashfrom Operating Activities
- 1.41
- Cashfrom Investing Activities
- -145.83
- Cashfrom Financing Activities
- 188.43
- Net Changein Cash
- 44.01
- Period
- 2021
- Total Revenue
- 336.42
- Selling/ General/ Admin Expenses Total
- 32.49
- Depreciation/ Amortization
- 6.9
- Other Operating Expenses Total
- 0.13
- Total Operating Expense
- 278.96
- Operating Income
- 57.46
- Net Income Before Taxes
- 44.22
- Net Income
- 31.33
- Diluted Normalized EPS
- 13.43
- Period
- 2021
- Total Assets
- 491.97
- Total Liabilities
- 308.94
- Total Equity
- 183.02
- Tangible Book Valueper Share Common Eq
- 78.29
- Period
- 2021
- Cashfrom Operating Activities
- 83.57
- Cashfrom Investing Activities
- -134.57
- Cashfrom Financing Activities
- 50.73
- Net Changein Cash
- -0.27
- Period
- 2020
- Total Revenue
- 306.12
- Selling/ General/ Admin Expenses Total
- 29.81
- Depreciation/ Amortization
- 5.24
- Other Operating Expenses Total
- 0.28
- Total Operating Expense
- 253.31
- Operating Income
- 52.81
- Net Income Before Taxes
- 41.1
- Net Income
- 28.66
- Diluted Normalized EPS
- 12.28
- Period
- 2020
- Total Assets
- 354.85
- Total Liabilities
- 198.6
- Total Equity
- 156.25
- Tangible Book Valueper Share Common Eq
- 66.82
- Period
- 2020
- Cashfrom Operating Activities
- -34.55
- Cashfrom Investing Activities
- -28.63
- Cashfrom Financing Activities
- 62.64
- Net Changein Cash
- -0.54
- Period
- 2019
- Total Revenue
- 239.06
- Selling/ General/ Admin Expenses Total
- 11.15
- Depreciation/ Amortization
- 2.84
- Other Operating Expenses Total
- 43.79
- Total Operating Expense
- 198.48
- Operating Income
- 40.58
- Net Income Before Taxes
- 29.34
- Net Income
- 21.04
- Diluted Normalized EPS
- 10.48
- Period
- 2019
- Total Assets
- 246.44
- Total Liabilities
- 176.24
- Total Equity
- 70.2
- Tangible Book Valueper Share Common Eq
- 34.91
- Period
- 2019
- Cashfrom Operating Activities
- -3.68
- Cashfrom Investing Activities
- -20.09
- Cashfrom Financing Activities
- 23.97
- Net Changein Cash
- 0.2
- Period
- 2025-03-31
- Total Revenue
- 202.82
- Selling/ General/ Admin Expenses Total
- 18.31
- Depreciation/ Amortization
- 6.76
- Other Operating Expenses Total
- 40.63
- Total Operating Expense
- 187.28
- Operating Income
- 15.54
- Net Income Before Taxes
- 3.68
- Net Income
- 2.41
- Diluted Normalized EPS
- 4.39
- Period
- 2025-03-31
- Total Assets
- 1747.31
- Total Liabilities
- 957.92
- Total Equity
- 789.39
- Tangible Book Valueper Share Common Eq
- 298.86
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 195.96
- Cashfrom Investing Activities
- -316.59
- Cashfrom Financing Activities
- 113.07
- Net Changein Cash
- -7.56
- Period
- 2024-12-31
- Total Revenue
- 201.43
- Selling/ General/ Admin Expenses Total
- 15.69
- Depreciation/ Amortization
- 7.1
- Other Operating Expenses Total
- 41.76
- Total Operating Expense
- 173.89
- Operating Income
- 27.54
- Net Income Before Taxes
- 15.25
- Net Income
- 10.01
- Diluted Normalized EPS
- 3.8
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 193.36
- Selling/ General/ Admin Expenses Total
- 14.83
- Depreciation/ Amortization
- 7.12
- Other Operating Expenses Total
- 34.19
- Total Operating Expense
- 165.97
- Operating Income
- 27.39
- Net Income Before Taxes
- 15.48
- Net Income
- 10.96
- Diluted Normalized EPS
- 4.15
- Period
- 2024-09-30
- Total Assets
- 1550.33
- Total Liabilities
- 773.14
- Total Equity
- 777.19
- Tangible Book Valueper Share Common Eq
- 294.21
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 72.65
- Cashfrom Investing Activities
- -163.19
- Cashfrom Financing Activities
- 84.3
- Net Changein Cash
- -6.24
- Period
- 2024-06-30
- Total Revenue
- 179.95
- Selling/ General/ Admin Expenses Total
- 16.01
- Depreciation/ Amortization
- 6.81
- Other Operating Expenses Total
- 36.76
- Total Operating Expense
- 155.96
- Operating Income
- 23.99
- Net Income Before Taxes
- 15.76
- Net Income
- 11.47
- Diluted Normalized EPS
- 4.35
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 199.65
- Selling/ General/ Admin Expenses Total
- 14.76
- Depreciation/ Amortization
- 5.86
- Other Operating Expenses Total
- 37.02
- Total Operating Expense
- 169.72
- Operating Income
- 29.93
- Net Income Before Taxes
- 22.47
- Net Income
- 16.93
- Diluted Normalized EPS
- 6.42
- Period
- 2024-03-31
- Total Assets
- 1461.4
- Total Liabilities
- 701.11
- Total Equity
- 760.29
- Tangible Book Valueper Share Common Eq
- 287.75
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -29.15
- Cashfrom Investing Activities
- -215.58
- Cashfrom Financing Activities
- 236.53
- Net Changein Cash
- -8.2
- Period
- 2023-12-31
- Total Revenue
- 164.44
- Selling/ General/ Admin Expenses Total
- 16.73
- Depreciation/ Amortization
- 5.74
- Other Operating Expenses Total
- 36.44
- Total Operating Expense
- 149.89
- Operating Income
- 14.55
- Net Income Before Taxes
- 5.7
- Net Income
- 1.06
- Diluted Normalized EPS
- 0.41
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Neogen Chemicals Technical
Moving Average
SMA
- 5 Day1545.62
- 10 Day1526.95
- 20 Day1549.98
- 50 Day1604.33
- 100 Day1786.66
- 300 Day1844.26
Neogen Chemicals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Bharat Rasayan
- 9780.5
- 66.45
- 0.68
- 14281.35
- 8811
- 4185.39
- Nacl Industries
- 191.05
- -10.05
- -5
- 220.1
- 48.6
- 3810.28
- Neogen Chemicals
- 1573.55
- 38.4
- 2.5
- 2414.9
- 1390.5
- 4152.64
- Bhagiradha Chemicals & Industri
- 299.2
- -0.85
- -0.28
- 448
- 175.1
- 3864.69
- Grauer & Weil (india)
- 84.53
- 2.22
- 2.7
- 120
- 72.16
- 3814.12
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Bharat Rasayan
- 42.15
- 4.07
- 19.64
- 12.19
- Nacl Industries
- -
- 7.89
- 7.92
- 2.29
- Neogen Chemicals
- 90.71
- 5.12
- 8.4
- 6.6
- Bhagiradha Chemicals & Industri
- 191.95
- 7.75
- 12.14
- 6.75
- Grauer & Weil (india)
- 26.75
- 4.86
- 17.09
- 11.93
Neogen Chemicals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 17-May-25
- Audited Results & Final Dividend
- 01-Feb-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 07-Aug-24
- Quarterly Results
- 30-Apr-24
- Audited Results & Final Dividend
- 09-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 05-Oct-23
- Preferential issue of shares
- 05-Aug-23
- Quarterly Results
- 13-May-23
- Audited Results & Final Dividend
- Meeting Date
- Announced on
- Purpose
- 07-Dec-24
- 29-Oct-24
- POM
- 27-Sept-24
- 07-Aug-24
- AGM
- 28-Oct-23
- 06-Oct-23
- EGM
- 05-Sept-23
- 07-Aug-23
- AGM
- -
- 09-Aug-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 19-May-25
- -
- -
- 1
- 02-May-24
- -
- 19-Sept-24
- 2
- 15-May-23
- -
- 25-Aug-23
- 3
- 31-May-21
- -
- 16-Sept-21
- 2.25


